Atossa Therapeutics
ATOS
$1.46
Share price
-2.01%
Change (1 day)
105.63%
Change (1 year)
Categories
Atossa Therapeutics (ATOS) - Net assets
Net assets on the balance sheet as of September 2023 : $98.25 M
According to Atossa Therapeutics's latest financial reports the company has $98.25 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Atossa Therapeutics - Net assets on balance sheet (from 2010 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.11 B | -14.6% |
| 2021-12-31 | $0.13 B | 408.45% |
| 2020-12-31 | $27.16 M | 106.51% |
| 2019-12-31 | $13.15 M | 49.41% |
| 2018-12-31 | $8.8 M | 26.9% |
| 2017-12-31 | $6.93 M | 124.04% |
| 2016-12-31 | $3.09 M | -17.23% |
| 2015-12-31 | $3.74 M | -60.61% |
| 2014-12-31 | $9.49 M | -10.41% |
| 2013-12-31 | $10.6 M | 104.84% |
| 2012-12-31 | $5.17 M | 231.82% |
| 2011-12-31 | $1.55 M | -283.1% |
| 2010-12-31 | $-0.86 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.02 B | 71,166.45% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $6.54 B | 6,562.53% | 🇺🇸 USA |
 LabCorp LH | $7.97 B | 8,016.76% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.92 B | 839.85% | 🇺🇸 USA |
 Enzo Biochem ENZ | $70.77 M | -27.97% | 🇺🇸 USA |